The Ambient Light Multiple Myeloma Study
NCT: NCT05737732 · RECRUITING
Brief Summary
The aim of this multi-site randomized control trial will be is to assess the impact Systematic lighting on circadian rhythm entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation. To achieve this aim, 200 multiple myeloma patients will receive one of two different light-treatments that are designed to promote circadian rhythm alignment. While receiving these light treatments, participants' sleep efficiency, urine melatonin levels, blood inflammatory cytokine levels and symptoms will be assessed over a 2-month period.
Frequently Asked Questions
What is The Ambient Light Multiple Myeloma Study?
The Ambient Light Multiple Myeloma Study is a clinical trial registered under NCT05737732. Current status: RECRUITING.
What is the status of NCT05737732?
The current status of NCT05737732 (The Ambient Light Multiple Myeloma Study) is: RECRUITING.
When did The Ambient Light Multiple Myeloma Study start?
The Ambient Light Multiple Myeloma Study started on 2023-02-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.